Thanks for posting. Just not sure the conclusion that PFA should now be the first-line intervention versus antiarrhythmics logically follows from the trial data. So if the idea is to compare PFA first versus standard of care (antiarrhythmics followed by ablation if needed), then that's what they should have compared. Not PFA first versus antiarrhythmics alone. It should also be noted that the trial was funded by Boston Scientific/FARAPULSE.
But what struck me most was the high procedural stroke rate in the PFA group. Six events out of the first 183 PFA patients! That was enough for the trial to be paused and the clot-prevention protocol changed before it could safely continue.
So if I ever had to have another ablation, especially being in a higher-risk group, I might insist on the revised protocol, including TEE within 24 hours of ablation to look for thrombus.
I also hope this finding is a wake-up call that more thrombus protection than currently offered may be needed in general. Especially in higher-risk ablation patients.
Jim
Edited 1 time(s). Last edit at 05/11/2026 06:01PM by mjamesone.